Year |
Citation |
Score |
2023 |
Nepomuceno TC, Foo TK, Richardson ME, Ranola JMO, Weyandt J, Varga MJ, Alarcon A, Gutierrez D, von Wachenfeldt A, Eriksson D, Kim R, Armel S, Iversen E, Couch FJ, Borg Å, et al. BRCA1 frameshift variants leading to extended incorrect protein C-termini. Hgg Advances. 100240. PMID 37718511 DOI: 10.1016/j.xhgg.2023.100240 |
0.747 |
|
2022 |
Deng O, Dash S, Nepomuceno TC, Fang B, Yun SY, Welsh EA, Lawrence HR, Marchion D, Koomen JM, Monteiro AN, Rix U. Integrated proteomics identifies PARP inhibitor-induced pro-survival signaling changes as potential vulnerabilities in ovarian cancer. The Journal of Biological Chemistry. 102550. PMID 36183837 DOI: 10.1016/j.jbc.2022.102550 |
0.689 |
|
2022 |
Nepomuceno TC, Dos Santos APP, Fernandes VC, Elias ABR, Gomes TT, Suarez-Kurtz G, Iversen ES, Couch FJ, Monteiro ANA, Carvalho MA. Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay. Scientific Reports. 12: 16203. PMID 36171434 DOI: 10.1038/s41598-022-20500-4 |
0.744 |
|
2022 |
Abreu RBV, Gomes TT, Nepomuceno TC, Li X, Fuchshuber-Moraes M, De Gregoriis G, Suarez-Kurtz G, Monteiro ANA, Carvalho MA. Functional Restoration of Nonsense Mutations by Aminoglycoside-Induced Readthrough. Frontiers in Pharmacology. 13: 935995. PMID 35837282 DOI: 10.3389/fphar.2022.935995 |
0.757 |
|
2021 |
Mendoza-Fandiño G, Lyra PCM, Nepomuceno TC, Harro CM, Woods NT, Li X, Rangel LB, Carvalho MA, Couch FJ, Monteiro ANA. Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locus. European Journal of Human Genetics : Ejhg. PMID 34803163 DOI: 10.1038/s41431-021-01005-6 |
0.735 |
|
2020 |
Nepomuceno TC, Carvalho MA, Rodrigue A, Simard J, Masson JY, Monteiro ANA. PALB2 Variants: Protein Domains and Cancer Susceptibility. Trends in Cancer. PMID 33139182 DOI: 10.1016/j.trecan.2020.10.002 |
0.752 |
|
2020 |
Lyra PCM, Nepomuceno TC, de Souza MLM, Machado GF, Veloso MF, Henriques TB, Dos Santos DZ, Ribeiro IG, Ribeiro RS, Rangel LBA, Richardson M, Iversen ES, Goldgar D, Couch FJ, Carvalho MA, et al. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 33087888 DOI: 10.1038/s41436-020-00991-0 |
0.731 |
|
2020 |
Golubeva VA, Nepomuceno TC, Gregoriis G, Mesquita RD, Li X, Dash S, Garcez PP, Suarez-Kurtz G, Izumi V, Koomen J, Carvalho MA, Monteiro ANA. Network of Interactions between ZIKA Virus Non-Structural Proteins and Human Host Proteins. Cells. 9. PMID 31936331 DOI: 10.3390/Cells9010153 |
0.649 |
|
2019 |
Golubeva VA, Nepomuceno TC, Monteiro ANA. Germline Missense Variants in : New Trends and Challenges for Clinical Annotation. Cancers. 11. PMID 31013702 DOI: 10.3390/cancers11040522 |
0.57 |
|
2019 |
Fernandes VC, Golubeva VA, Di Pietro G, Shields C, Amankwah K, Nepomuceno TC, de Gregoriis G, Abreu RBV, Harro C, Gomes TT, Silva RF, Suarez-Kurtz G, Couch F, Iversen ES, Monteiro ANA, et al. Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation. The Journal of Biological Chemistry. PMID 30765603 DOI: 10.1074/Jbc.Ra118.005274 |
0.75 |
|
2017 |
Nepomuceno TC, De Gregoriis G, de Oliveira FMB, Suarez-Kurtz G, Monteiro AN, Carvalho MA. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition. International Journal of Molecular Sciences. 18. PMID 28858227 DOI: 10.3390/ijms18091886 |
0.75 |
|
2017 |
Nepomuceno TC, Fernandes VC, Gomes TT, Carvalho RS, Suarez-Kurtz G, Monteiro AN, Carvalho MA. BRCA1 recruitment to damaged DNA sites is dependent on CDK9. Cell Cycle (Georgetown, Tex.). 1-8. PMID 28278048 DOI: 10.1080/15384101.2017.1295177 |
0.722 |
|
2014 |
Carvalho RS, Fernandes VC, Nepomuceno TC, Rodrigues DC, Woods NT, Suarez-Kurtz G, Chammas R, Monteiro AN, Carvalho MA. Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biology & Therapy. 15: 840-50. PMID 24755837 DOI: 10.4161/Cbt.28873 |
0.761 |
|
Show low-probability matches. |